0000929638-25-002712.txt : 20250725 0000929638-25-002712.hdr.sgml : 20250725 20250724210545 ACCESSION NUMBER: 0000929638-25-002712 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20250725 DATE AS OF CHANGE: 20250724 EFFECTIVENESS DATE: 20250725 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Medcura, Inc. CENTRAL INDEX KEY: 0001672180 ORGANIZATION NAME: EIN: 260649449 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-552768 FILM NUMBER: 251148386 BUSINESS ADDRESS: STREET 1: 5650 RIVERTECH COURT, SUITE S CITY: RIVERDALE STATE: MD ZIP: 20737 BUSINESS PHONE: 301-405-3585 MAIL ADDRESS: STREET 1: 5650 RIVERTECH COURT, SUITE S CITY: RIVERDALE STATE: MD ZIP: 20737 FORMER COMPANY: FORMER CONFORMED NAME: gel-e, Inc. DATE OF NAME CHANGE: 20160919 FORMER COMPANY: FORMER CONFORMED NAME: Remedium Technologies, INC. DATE OF NAME CHANGE: 20160413 D 1 primary_doc.xml X0708 D LIVE 0001672180 Medcura, Inc. 5650 RIVERTECH COURT, SUITE S RIVERDALE MD MARYLAND 20737 3014053585 DELAWARE Remedium Technologies, Inc. gel-e, Inc. Remedium Technologies, INC. Corporation true Jim Buck c/o Medcura, Inc. 5650 Rivertech Court, Suite S Riverdale MD MARYLAND 20737 Director Executive Officer Mr. Buck is the President and Chief Executive Officer of the Issuer. Larry Tiffany c/o Medcura, Inc. 5650 Rivertech Court, Suite S Riverdale MD MARYLAND 20737 Director Executive Officer Mr. Tiffany is the Executive Chairman of the Issuer. Matthew Dowling, Ph.D c/o Medcura, Inc. 5650 Rivertech Court, Suite S Riverdale MD MARYLAND 20737 Director Executive Officer Dr. Dowling is the Chief Scientic Officer of the Issuer. Rich Vincent c/o Medcura, Inc. 5650 Rivertech Court, Suite S Riverdale MD MARYLAND 20737 Executive Officer Mr. Vincent is the Chief Financial Officer of the Issuer. Abbas Ardehali, M.D. c/o Medcura, Inc. 5650 Rivertech Court, Suite S Riverdale MD MARYLAND 20737 Director Biotechnology Decline to Disclose 06b false 2025-04-16 false true true Convertible Promissory Notes; Series B Preferred Stock underlying the convertible promissory notes false 0 38286410 28548588 9737822 false 174 0 52183 0 false Medcura, Inc. /s/ Jim Buck Jim Buck President and CEO for the Issuer 2025-07-24